Swiss Healthtech Stock News

SWX:BSLN
SWX:BSLNBiotechs

Basilea Pharmaceutica (SWX:BSLN) Margin Slide Challenges Bullish Growth Narratives After FY 2025 First Half

Basilea Pharmaceutica (SWX:BSLN) has just posted its FY 2025 numbers with first half revenue of CHF103.96 million and basic EPS of CHF1.29, following FY 2024 second half revenue of CHF132.25 million and basic EPS of CHF4.70. The company has seen revenue move from CHF76.29 million in FY 2024 first half to CHF132.25 million in second half and then CHF103.96 million in FY 2025 first half, while basic EPS shifted from CHF1.72 to CHF4.70 and then CHF1.29. This sets up a results picture that puts...
SWX:SPSN
SWX:SPSNReal Estate

Swiss Prime Site’s Valuation After Dividend Hike And Stronger 2025 Earnings

Swiss Prime Site (SWX:SPSN) drew fresh attention after reporting full year 2025 earnings along with a proposed dividend increase to CHF 3.50 per share, with shareholders set to vote at the 12 March 2026 AGM. See our latest analysis for Swiss Prime Site. The proposed dividend increase and solid full year 2025 earnings come after a strong run in the share price, with a 90 day share price return of 17.63%, a 1 year total shareholder return of 29.71% and a 3 year total shareholder return of...
SWX:ALSN
SWX:ALSNElectronic

A Look At ALSO Holding (SWX:ALSN) Valuation After Earnings Call And Higher Dividend Announcement

Earnings call and dividend decision draw focus to ALSO Holding (SWX:ALSN) ALSO Holding (SWX:ALSN) is back on investor radars after its 2025 earnings call on 17 February 2026 coincided with the announcement of an annual dividend of CHF 5.30 per share. See our latest analysis for ALSO Holding. The earnings call and dividend announcement came against a weak backdrop, with a 1 day share price return of 31.17% decline and a 1 year total shareholder return of 46.43% decline suggesting momentum has...
SWX:ALC
SWX:ALCMedical Equipment

Is There Now An Opportunity In Alcon (SWX:ALC) After A 23.6% Share Price Drop

This article is designed to help you think clearly about whether Alcon's current share price fairly reflects its potential or if the market might be mispricing it. Alcon closed at $61.90, with a 1.4% gain over the last 7 days, a 3.2% decline over 30 days, a 2.6% decline year to date, and a 23.6% decline over the past year, which may catch the eye of investors reassessing the balance between opportunity and risk. Recent headlines around Alcon have focused on its position within healthcare and...
SWX:SGKN
SWX:SGKNBanks

A Look At St. Galler Kantonalbank (SWX:SGKN) Valuation After Full-Year Results And Dividend Announcement

Why St. Galler Kantonalbank’s latest results matter for shareholders St. Galler Kantonalbank (SWX:SGKN) has caught investor attention after reporting full year 2025 results, with higher net interest income and net income, alongside an annual dividend announcement of CHF 20.00 per share. See our latest analysis for St. Galler Kantonalbank. The latest earnings and dividend news comes after a strong run in the share price, with a 90 day share price return of 18.10% and a 1 year total shareholder...
SWX:BCVN
SWX:BCVNBanks

European Dividend Stocks To Consider In February 2026

As European markets navigate volatility amid AI disruption concerns and digest strong U.S. job data, the pan-European STOXX Europe 600 Index managed to hit a new high, reflecting resilience in the region's economy. In such an environment, dividend stocks can offer investors a measure of stability and income potential, making them an attractive consideration for those looking to balance growth with steady returns.
SWX:ABBN
SWX:ABBNElectrical

Is It Too Late To Consider ABB (SWX:ABBN) After Its Strong Multi‑Year Share Price Run?

If you are wondering whether ABB is still fairly priced after a strong run, this article will walk through what the current share price might be implying about value. ABB's share price closed at CHF 69.80, with returns of 1.7% over 7 days, 13.3% over 30 days, 14.0% year to date, 34.5% over 1 year, 139.7% over 3 years and 215.6% over 5 years. This raises the question of what is already reflected in the price. Recent news around ABB has focused on its position as a global industrial technology...
SWX:NOVN
SWX:NOVNPharmaceuticals

Novartis (SWX:NOVN): Are Renal Bets And Radiopharmaceuticals Quietly Reshaping Its Long-Term Growth Mix?

In early February 2026, Novartis reported final Phase III ALIGN data showing Vanrafia® (atrasentan) slowed kidney function decline in adults with IgA nephropathy, alongside a new long-term Actinium-225 supply agreement from Niowave to support its radioligand therapy portfolio for difficult-to-treat cancers. Together, these updates highlight Novartis’ effort to build depth in both renal disease and radiopharmaceutical oncology, reinforcing the importance of specialized therapies and secure...
SWX:SREN
SWX:SRENInsurance

3 European Dividend Stocks Yielding Up To 5.3%

As European markets navigate volatility, with the STOXX Europe 600 Index recently hitting a new high before settling nearly unchanged, investors are keenly observing economic indicators such as employment growth and GDP expansion in the eurozone. Amidst these dynamics, dividend stocks have gained attention for their potential to provide steady income; qualities like strong cash flow and a history of consistent payouts can make them appealing choices in uncertain market conditions.
SWX:SCMN
SWX:SCMNTelecom

Swisscom (SWX:SCMN) Valuation Check After Earnings Update And CHF 26 Dividend Proposal

Why Swisscom’s latest earnings and dividend move matter for shareholders Swisscom (SWX:SCMN) shares are in focus after the company paired its full year 2025 earnings release with a proposed CHF 26.00 per share annual dividend, drawing attention to both profitability and cash returns. See our latest analysis for Swisscom. That mix of a lower net income figure alongside solid operational progress and a proposed CHF 26.00 dividend appears to have caught the market’s eye. A 1 month share price...
SWX:LISN
SWX:LISNFood

Is Lindt’s DubaiStyle Expansion a Clue to Its Everyday Indulgence Strategy for (SWX:LISN) Investors?

In February 2026, Lindt & Sprüngli confirmed the return of its sold‑out DubaiStyle Chocolate to Canadian shelves, reintroducing the 150g bar and adding a new 40g snackable format crafted with smooth milk chocolate, pistachio filling and kadayif pastry. The launch of a portable 40g DubaiStyle bar alongside the original 150g format highlights how Lindt is using premium, culturally inspired recipes to broaden everyday indulgence occasions. We’ll now examine how expanding DubaiStyle into a new...
SWX:TEMN
SWX:TEMNSoftware

Temenos (SWX:TEMN) Valuation Check After New Mibanco SaaS Banking Deal

Temenos (SWX:TEMN) has drawn fresh attention after Peru based Mibanco selected its SaaS platform, including Temenos Core and Data Hub, to modernize core banking and support micro and small businesses across the country. See our latest analysis for Temenos. Despite winning new SaaS clients like Mibanco, Temenos has faced selling pressure, with a 30 day share price return showing an 18.75% decline and a 1 year total shareholder return indicating a 19.27% loss, suggesting sentiment has weakened...
SWX:BCHN
SWX:BCHNMachinery

Top 3 European Dividend Stocks Offering Up To 5% Yield

As European markets experience volatility amidst global concerns about AI disruption and economic data releases, the pan-European STOXX Europe 600 Index has managed to reach new highs, reflecting a complex investment landscape. In such an environment, dividend stocks can offer a measure of stability and income potential for investors seeking to navigate these uncertain times.
SWX:VATN
SWX:VATNBanks

Valiant Holding (SWX:VATN) Valuation Check After Announced Annual Dividend For Shareholders

Valiant Holding (SWX:VATN) has announced an annual dividend of CHF 6.00 per share, with an ex dividend date on May 18, 2026, a record date on May 19, and payment on May 20. See our latest analysis for Valiant Holding. The dividend announcement comes as Valiant Holding’s share price has moved to CHF 162.8, with a 30 day share price return of 4.23% and a 90 day share price return of 20.06%. The 1 year total shareholder return of 52.03% and 5 year total shareholder return of 127.20% point to...
SWX:LONN
SWX:LONNLife Sciences

A Look At Lonza Group’s (SWX:LONN) Valuation After Its Governance And Board Refresh

Board overhaul puts Lonza Group (SWX:LONN) governance in focus Lonza Group (SWX:LONN) has set out a broad board refresh, nominating tech-focused leader Sami Atiya and proposing Claudia Süssmuth-Dyckerhoff as Vice-Chair while several long-serving directors prepare to step down. See our latest analysis for Lonza Group. The board refresh headlines come at a time when Lonza Group’s 1-day share price return of 1.19% and 7-day share price return of 2.21% sit against a 1-year total shareholder...
SWX:ABBN
SWX:ABBNElectrical

Assessing ABB (SWX:ABBN) Valuation After Strong Q4, New Buyback And Electrification Contract Wins

ABB (SWX:ABBN) is back in focus after reporting strong Q4 results, growing orders, and outlining a CHF2.0b share buyback, alongside new contract wins in power and data centre electrification. See our latest analysis for ABB. ABB’s recent Q4 update, the CHF2.0b share buyback and new electrification contracts have arrived alongside a 30 day share price return of 13.6% and a 1 year total shareholder return of 37.6%. Together these developments point to strengthening momentum rather than a short...
SWX:IDIA
SWX:IDIABiotechs

Idorsia (SWX:IDIA) Valuation Check After Lucerastat Phase 3 Agreement With US And European Regulators

Idorsia (SWX:IDIA) is back on investors’ radar after securing regulator alignment in the US and Europe on a streamlined Phase 3 registration program for its Fabry disease candidate, lucerastat. See our latest analysis for Idorsia. The latest lucerastat update lands after a sharp swing in sentiment, with Idorsia’s 1 year total shareholder return very large at about 5.3x. However, the year to date share price return is slightly negative and longer term total shareholder returns over 3 and 5...
SWX:ACLN
SWX:ACLNElectrical

How Accelleron’s Board Succession Overhaul Will Impact Accelleron Industries (SWX:ACLN) Investors

Accelleron Industries has announced a major reshaping of its Board of Directors, proposing Monika Krüsi as Chairwoman and adding Mieke Van de Capelle, while two current directors step down early as part of an accelerated succession plan ahead of the 28 April 2026 AGM. This governance renewal could recalibrate how the company sets priorities in areas such as nomination, compensation, and sustainability oversight, potentially influencing its long-term direction. We’ll now examine how this...
SWX:UBSG
SWX:UBSGCapital Markets

Assessing UBS Group (SWX:UBSG) Valuation After Recent Share Price Volatility

Recent performance and context for UBS Group shares UBS Group (SWX:UBSG) has drawn investor attention after a monthly return of about a 16% decline and a 3‑month gain of roughly 4%, set against a backdrop of mixed shorter-term price moves. See our latest analysis for UBS Group. At a share price of CHF32.10, UBS Group’s recent 1 month share price return of a 16% decline and 7 day share price return of a 5% decline contrast with a 1 year total shareholder return of 9.8% and 5 year total...